Status:
RECRUITING
COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Lead Sponsor:
University Hospital, Akershus
Collaborating Sponsors:
St. Olavs Hospital
Helse Stavanger HF
Conditions:
Pediatric Respiratory Diseases
COVID
Eligibility:
All Genders
Up to 18 years
Brief Summary
Prospective cohort study of COVID-19 infection among children in Norway.
Detailed Description
This nation-wide, prospective cohort study of COVID-19 infection addresses three main issues: 1) Epidemiological risk factors; 2) Natural history (including immunological mechanisms and long term effe...
Eligibility Criteria
Inclusion
- Suspected covid-19 infection and age 0-18 years
Exclusion
- Age \>18 years
Key Trial Info
Start Date :
April 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04335773
Start Date
April 3 2020
End Date
December 31 2030
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus universistetssykehus
Lørenskog, Norway